MOESM9 of Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting
Year: 2019
Type: dataset
Abstract: Additional file 9: Figure S2. Resistant cell lines correlate with activation of ErbB/PI3K pathway.
Source: Figshare
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4394229529
